Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hai Kang Life is a Hong Kong-based molecular diagnostics company focused on point-of-care and laboratory diagnostic products for infectious disease detection, pharmacogenomics, prenatal and genetic screening, veterinary testing, and food safety testing. The company markets clinical, COVID-19, veterinary, and food-testing kits and highlights proprietary electric-field-assisted-diagnostic technology designed for multiplex pathogen detection. Hai Kang Life also operates testing and R&D capabilities in Hong Kong and Beijing and positions itself around personalized medicine and pathogen surveillance. Founded in 1999, the company appears to be an active private healthcare company rather than a therapeutics developer, with commercial diagnostic products rather than a traditional drug pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hai Kang Life Corporation.